Last reviewed · How we verify

NCT04841460

Impact of Beef's Unique Food Matrix on Human Health

Completed NA Last updated 12 April 2021
What this trial tests

NA trial testing Low-fat ground beef in Cholesterol, LDL in 25 participants. Completed in 30 September 2019.

Timeline
18 February 2019
Primary endpoint
19 July 2019
30 September 2019

Quick facts

Lead sponsorTexas A&M University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment25
Start date18 February 2019
Primary completion19 July 2019
Estimated completion30 September 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Texas A&M University

Who can join

Eligibility, male only, with Cholesterol, LDL or Cholesterol, HDL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. This specifically addresses the hypothesis that increasing the amount of fat in ground beef reduces risk factors for cardiovascular disease. Also, the investigators will measure changes in glucose, insulin, and triacylglycerols (TAG) following low-fat and high-fat ground beef interventions. An important aspect of this research is that the investigators will confirm that consumption of high-fat ground beef will reduce carbohydrate intake and increase insulin sensitivity in men. Furthermore, the investigators will be able to establish which protein sources are voluntarily replaced by the low- and high-fat ground beefs.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Consuming High-Fat and Low-Fat Ground Beef Depresses High-Density and Low-Density Lipoprotein Cholesterol Concentrations, and Reduces Small, Dense Low-Density Lipoprotein Particle Abundance.
    Lytle JR, Price T, Crouse SF, Smith DR, et al · · 2023 · cited 4× · PMID 36678207 · DOI 10.3390/nu15020337
  2. Assessment of Vascular Function in Response to High-Fat and Low-Fat Ground Beef Consumption in Men.
    Lytle JR, Stanelle ST, Martin SE, Smith SB, et al · · 2023 · cited 2× · PMID 36986140 · DOI 10.3390/nu15061410
  3. High unprocessed beef intake (>100 g/d) linked to elevated triglyceride levels: evidence from cross-sectional and Mendelian randomization in Chinese and American adult populations.
    Yi Z, Ding S, Liu X, Liu S, et al · · 2026 · PMID 42221767 · DOI 10.3389/fnut.2026.1790394

Verify or expand the search:

Other Texas A&M University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04841460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing